Strategic Acquisition The recent acquisition of Evoke Neuroscience by Firefly Neuroscience signals a significant expansion in their technological capabilities and market reach, creating opportunities to bundle and cross-sell advanced brain health assessment solutions to existing and new clients.

Government & Military Contracts Evoke Neuroscience has demonstrated its capability to secure high-profile government contracts, such as with the U.S. Air Force, indicating strong credibility and the potential to target other federal agencies and defense sectors with specialized brain health diagnostics.

Innovative Tech Stack Evoke’s FDA-cleared EEG system and focus on brain biomarkers present a unique selling point for healthcare providers and research institutions seeking cutting-edge, non-invasive solutions for cognitive impairment diagnosis and management.

Market Growth & Recognition Recognition as one of America's fastest-growing private companies and winning innovation awards underscore Evoke's rising profile, making it an attractive partner or customer for organizations focused on emerging medical device technologies and brain health.

Potential Expansion Areas With total revenues between 1 million and 10 million and a relatively small team, Evoke presents growth opportunities in expanding sales channels, international markets, and partnerships with hospitals, military, and academic research centers to increase market penetration.